Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Onconic Therapeutics logo — company profile

Onconic Therapeutics

Founded 2020 Korea South Korea South 10 employees Series B Total: $26.00B Health and Wellness, Pharmaceutical

General Information

Company Name Onconic Therapeutics
Founded Year 2020
Location Korea South Korea South
Employees 10
Industries Health and Wellness, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Onconic Therapeutics. To contact Onconic Therapeutics, visit onconic.co.kr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Onconic Therapeutics

Onconic Therapeutics is a 2020-founded startup based in Korea South, operating in the Health and Wellness and Pharmaceutical industries. The company recently secured a significant KRW26.00B Series B investment on 09 December 2022. The investment was led by a consortium of prominent investors including Aju IB Investment, Korea Development Bank, Premier Partners, K2 Investment Partners, Stonebridge Ventures, BNH Investment, Dt& Investment, SL Investment, and DAOL Investment. Onconic Therapeutics' innovative approach and notable investment raise signify its potential for growth and disruption within the healthcare and pharmaceutical sectors. This recent investment marks a key milestone in the company's journey, positioning it for further expansion, development, and impact within the industry.

Taxonomy: investment, startups

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B KRW26.00B 9
Aju IB Investment Korea Development Bank Premier Partners
Aju IB Investment, Korea Development Bank +7
09 Dec 2022

Onconic Therapeutics Alternatives & Competitors

View All Alternatives
Onconic Therapeutics vs
Journey Colab
Journey Colab United States

We are on a mission to develop FDA-approved, psychedelic therapies, starting with synthetic mescalin...

Venture round
14 employees
Health Care, Health and Wellness
Onconic Therapeutics vs
MDVerse
MDVerse United States

MDVerse

Seed
2 employees
Biotechnology, Health and Wellness
Onconic Therapeutics vs
1001PHARMACIES.COM
1001PHARMACIES.COM France

1001pharmacies est le premier site français de vente en ligne de produits de santé. Le site est l...

Series A
4 employees
E-Commerce, Health Care
View all alternatives

FAQ About Onconic Therapeutics

Website
Onconic Therapeutics was founded in 2020.
Onconic Therapeutics is headquartered in Korea South.
Onconic Therapeutics operates in Health and Wellness and Pharmaceutical. Its work centres on investment and startups.
Onconic Therapeutics has approximately 10 employees.
Onconic Therapeutics has completed 1 funding round, raising a total of $26.00B. The latest funding stage is Series B.
Top alternatives and competitors to Onconic Therapeutics include Journey Colab , MDVerse, 1001PHARMACIES.COM, NGT , Geolab SA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Onconic Therapeutics and Journey Colab are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Onconic Therapeutics, https://bouncewatch.com/company/onconic-therapeutics, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes